Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
International Angiology : a Journal of the International Union of Angiology|February 16, 2008
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical useO E Dahl, L C Borris, D Bergqvist, et al.The New England Journal of Medicine|January 17, 2002
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgeryB I Eriksson, K A Bauer, M R Lassen, et al.The New England Journal of Medicine|January 17, 2002
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgeryK A Bauer, B I Eriksson, M R Lassen, et al.Thrombosis Research|April 1, 1994
Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparinR Kijowski, D Hoppensteadt, J Walenga, et al.Journal of Thrombosis and Haemostasis : JTH|November 3, 2009
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patientsS Schulman, U Angerås, D Bergqvist, et al.Journal of Thrombosis and Haemostasis : JTH|September 18, 2007
The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacementM R Lassen, B L Davidson, A Gallus, et al.Journal of Thrombosis and Haemostasis : JTH|February 4, 2009
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging studyM R Lassen, O E Dahl, P Mismetti, et al.Seminars in Thrombosis and Hemostasis|January 1, 1991
Biological tolerance of Logiparin, a low molecular weight heparin used in patients undergoing total hip replacementH M Christiansen, M Rud-Lassen, L C Borris, et al.The British Journal of Surgery|June 1, 1992
Prevention of venous thromboembolism after surgery: a review of enoxaparinD Bergqvist, G D Lowe, A Berstad, et al.Thrombosis Research|July 21, 1998
Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) StudyM R Lassen, L C Borris, B S Anderson, et al.Pageof 7